Mitoferrin-2 (MFRN2), also known as solute carrier family 25 member 28 (SLC25A28), is a key mitochondrial iron transporter that regulates mitochondrial iron metabolism . It facilitates the transfer of cytosolic iron into mitochondria, a process vital for heme synthesis and iron-sulfur cluster assembly . In Xenopus laevis, the recombinant form, Mitoferrin-2B (slc25a28-b), is of particular interest in studies of angiogenesis, lymphangiogenesis, and other developmental processes .
| Gene Name | SLC25A28 |
|---|---|
| Alias | Mitoferrin-2 (MFRN2) |
| Organism | Xenopus laevis |
| Function | Transports iron into mitochondria for various metabolic processes |
| Related Pathways | Heme synthesis, iron-sulfur cluster assembly |
Mitoferrin-2 plays a crucial role in cellular and mitochondrial iron homeostasis . It is essential for the biogenesis of iron-sulfur clusters and heme, which are critical components of various proteins involved in cellular respiration and other metabolic functions .
Iron Import: MFRN2 mediates the import of iron into mitochondria, which is required for synthesizing heme-containing proteins and Fe/S cluster assembly in non-erythroid cells .
Non-Erythroid Cells: Mitoferrin-2 is vital in non-erythroid cells, whereas mitoferrin-1 is essential when the demand for mitochondrial iron is high .
Regulation: Posttranscriptional mechanisms regulate the expression of mitoferrin-1 and mitoferrin-2 .
Pulmonary Fibrosis: MFRN2 is upregulated in alveolar type II epithelial cells (AECII) during pulmonary fibrosis, leading to mitochondrial iron deposition and cell injury . Overexpression of MFRN2 enhances mitochondrial iron deposition, resulting in mtDNA damage and decreased cell viability .
IREB2 Regulation: Iron regulatory element-binding protein 2 (IREB2) can upregulate MFRN2 expression. Studies show that increased IREB2 levels promote MFRN2 expression in cells injured by bleomycin (BLM) .
Therapeutic Target: Mitoferrin 2 (MFRN2) has been identified as a therapeutic target for chromosome 8p deleted cancers .
Xenopus tadpoles have been utilized in chemical library screens to identify compounds and biological mechanisms involved in angiogenesis and lymphangiogenesis . These studies have identified several compounds that interfere with blood vascular and/or lymphatic development .
Mitoferrin-2B is a mitochondrial iron transporter mediating iron uptake. It is likely crucial for heme synthesis in hemoproteins and Fe-S cluster assembly in non-erythroid cells. The iron, presumably delivered as Fe2+, is then likely transferred to ferrochelatase to catalyze the incorporation of Fe2+ into protoporphyrin IX for heme production.
KEGG: xla:447330
UniGene: Xl.80320
Mitoferrin-2B (slc25a28-b) is a mitochondrial iron transporter protein belonging to the solute carrier family 25, member 28-B. In Xenopus laevis, this protein plays a crucial role in iron homeostasis by facilitating iron import into mitochondria. The full-length protein consists of 186 amino acids and functions as part of the cellular machinery responsible for iron metabolism . As iron is essential for various metabolic processes including heme synthesis and iron-sulfur cluster formation, Mitoferrin-2B is likely involved in developmental processes and cellular respiration in Xenopus laevis, similar to its function in other vertebrates. The protein is encoded by the slc25a28-b gene, which has synonyms including mfrn2-b and is identified by UniProt ID Q68F18 .
For optimal retention of Mitoferrin-2B activity, researchers should follow these evidence-based storage and reconstitution protocols:
Storage conditions:
Store lyophilized protein at -20°C to -80°C upon receipt
Aliquot reconstituted protein to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
For long-term storage, add glycerol to a final concentration of 5-50% (50% is recommended) and store at -20°C to -80°C
Reconstitution protocol:
Briefly centrifuge the vial prior to opening to collect contents at the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
The protein is supplied in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0, which helps maintain stability
It's important to note that repeated freeze-thaw cycles significantly reduce protein activity and should be avoided through proper aliquoting after initial reconstitution.
Xenopus laevis offers several unique advantages for studying mitochondrial iron transport proteins like Mitoferrin-2B:
Evolutionary position: As an amphibian, Xenopus occupies a phylogenetically intermediate position between aquatic vertebrates and land tetrapods, allowing comparative studies of conserved mechanisms across vertebrate evolution .
Experimental accessibility: The large, abundant eggs and readily manipulated embryos facilitate various experimental approaches, including microinjection of mRNAs or morpholinos targeting Mitoferrin-2B .
Developmental biology applications: Xenopus embryos develop externally and rapidly, enabling real-time observation of iron transport during developmental processes .
Conserved genomic organization: Xenopus shares conserved cellular, developmental, and genomic organization with mammals, making findings potentially translatable to human biology .
Cell-free systems: Xenopus egg extracts can be used to study mitochondrial protein function in a controlled biochemical environment .
While X. laevis is allotetraploid (with potential gene duplications), researchers can use X. tropicalis (diploid) as a complementary model when genetic manipulation is required .
For investigating Mitoferrin-2B's role in iron transport during Xenopus embryonic development, researchers should consider these methodological approaches:
Functional analysis approaches:
Morpholino-mediated knockdown: Antisense morpholino oligonucleotides can be designed to target slc25a28-b mRNA. These can be microinjected into early embryos to study loss-of-function phenotypes related to iron transport deficiency .
mRNA overexpression: Microinjection of synthesized mRNA encoding wildtype or mutant forms of Mitoferrin-2B can be used for gain-of-function or dominant negative studies .
CRISPR/Cas9 genome editing: While traditionally challenging in X. laevis due to its allotetraploid genome, targeted mutagenesis can be accomplished (particularly in X. tropicalis) to create genetic models of Mitoferrin-2B dysfunction .
Iron transport assessment techniques:
Radioactive iron (⁵⁵Fe) uptake assays: To directly measure mitochondrial iron import in isolated mitochondria from Xenopus embryos at different developmental stages.
Fluorescent iron sensors: Genetically-encoded or chemical probes can be used to visualize iron distribution in living embryos.
Whole mount in situ hybridization: To examine spatial and temporal expression patterns of slc25a28-b during development.
Biochemical fractionation: To assess iron content in mitochondrial versus cytosolic compartments using spectrophotometric methods or inductively coupled plasma mass spectrometry (ICP-MS).
For developmental phenotyping, researchers should monitor hematological parameters, as iron deficiency would affect hemoglobin synthesis during tadpole development.
Structure-function relationship studies of Mitoferrin-2B can be conducted using the following systematic approaches:
1. Domain mapping and mutagenesis:
Generate truncated versions or site-directed mutants of the recombinant protein
Focus on conserved regions identified through sequence alignment with Mitoferrin homologs
Express mutant constructs in systems lacking endogenous Mitoferrin activity
Assess functional impact on iron transport using radioactive iron uptake assays or complementation studies
2. Protein interaction studies:
Use recombinant His-tagged Mitoferrin-2B for pull-down assays to identify binding partners
Employ techniques like co-immunoprecipitation following in vitro translation in Xenopus egg extracts
Validate interactions through surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC)
3. Reconstitution in artificial membrane systems:
Incorporate purified recombinant Mitoferrin-2B into liposomes or nanodiscs
Measure direct transport activity using iron-sensitive fluorescent dyes
Determine kinetic parameters (Km, Vmax) for iron transport
4. Structural biology approaches:
Generate protein crystals for X-ray crystallography
Use cryo-electron microscopy for structural determination
Apply molecular dynamics simulations to predict conformational changes during transport
The amino acid sequence data available for the recombinant protein (186 amino acids) provides a foundation for designing these experiments, enabling precise targeting of functionally important residues .
Researchers targeting slc25a28-b in Xenopus face several technical challenges that require careful experimental design:
1. Genome duplication considerations:
Xenopus laevis has an allotetraploid genome, potentially containing duplicate copies of slc25a28-b
Complete knockdown may require targeting multiple paralogs simultaneously
X. tropicalis (diploid) may offer a simpler genetic background for clean knockdown studies
2. Morpholino design and validation:
Morpholinos are effective for the first few days of development but have temporal limitations
Careful design to avoid off-target effects is essential
Western blotting with specific antibodies should verify protein reduction
Rescue experiments with morpholino-resistant mRNA constructs are necessary to confirm specificity
3. Functional redundancy:
Other mitochondrial iron transporters might compensate for Mitoferrin-2B loss
May require simultaneous knockdown of multiple transporters
Consider tissue-specific effects where compensation mechanisms might differ
4. Developmental timing:
Early embryonic lethality might obscure later phenotypes
Consider using inducible or tissue-specific knockdown strategies
Employ partial knockdowns to study hypomorphic phenotypes
5. Phenotypic assessment:
Iron-related phenotypes may be subtle or manifest only under iron stress conditions
Combine molecular, cellular, and physiological readouts
Use complementary approaches like CRISPR/Cas9 mutagenesis for validation
Using antisense oligonucleotides has previously yielded insights into developmental pathways in Xenopus, such as the β-catenin signaling pathway, providing precedent for successful knockdown strategies .
Distinguishing between the functions of different mitochondrial iron transporters in Xenopus requires a multi-faceted experimental approach:
1. Expression pattern analysis:
Perform quantitative RT-PCR to determine tissue-specific and developmental stage-specific expression patterns
Use in situ hybridization to visualize spatial expression differences
Generate reporter constructs with promoters from different transporters
2. Substrate specificity determination:
Conduct in vitro transport assays using purified recombinant proteins
Test different metal ions beyond iron (zinc, copper, manganese) to identify transporter preferences
Determine kinetic parameters for different substrates
3. Selective genetic manipulation:
Design highly specific morpholinos or CRISPR/Cas9 guide RNAs targeting unique sequences
Create transporter-specific dominant negative constructs by mutating key residues
Perform selective rescue experiments with different transporters
4. Protein interaction network mapping:
Identify transporter-specific binding partners through proteomics approaches
Investigate whether transporters form distinct complexes with different auxiliary proteins
Determine if transporters localize to different mitochondrial subcompartments
5. Physiological response assessment:
Investigate differential responses to iron deficiency or overload
Examine transporter regulation under various stress conditions
Assess tissue-specific phenotypes following selective knockdown
Using the well-characterized Xenopus model system with its genetic and genomic tools enables these comparative approaches to reveal the distinct roles of Mitoferrin-2B versus other iron transporters .
To investigate potential interactions between Mitoferrin-2B and heme biosynthesis during Xenopus development, researchers should consider this systematic experimental workflow:
1. Co-expression analysis:
Perform temporal expression profiling of Mitoferrin-2B alongside key heme biosynthesis enzymes (ALAS, FECH, etc.)
Use single-cell RNA sequencing of developing embryos to identify cell populations with coordinated expression
Generate reporter lines for simultaneous visualization of expression patterns
2. Metabolic impact studies:
Measure heme synthesis rates in embryos with Mitoferrin-2B knockdown/overexpression
Quantify heme precursor accumulation using chromatography and mass spectrometry
Assess activity of iron-dependent enzymes in the heme biosynthetic pathway
3. Protein-protein interaction mapping:
Perform co-immunoprecipitation with tagged Mitoferrin-2B to identify interactions with heme biosynthesis enzymes
Use proximity labeling approaches (BioID, APEX) in Xenopus embryos to identify proteins in close proximity to Mitoferrin-2B
Validate direct interactions through in vitro binding assays with purified recombinant proteins
4. Subcellular co-localization:
Generate fluorescently tagged fusion proteins to visualize Mitoferrin-2B localization relative to heme biosynthesis enzymes
Use super-resolution microscopy to determine precise spatial relationships
Perform fractionation studies to biochemically confirm co-localization
5. Rescue experiments:
Test if heme or heme precursors can rescue phenotypes caused by Mitoferrin-2B deficiency
Evaluate if overexpression of heme biosynthesis enzymes can compensate for Mitoferrin-2B knockdown
Since Xenopus has been used extensively for developmental biology and cell biological studies, these approaches can leverage the system's strengths while providing mechanistic insights into iron utilization pathways .
To ensure experimental reliability and reproducibility when working with recombinant Mitoferrin-2B, researchers should implement the following quality control measures:
1. Protein integrity verification:
SDS-PAGE analysis to confirm the expected molecular weight (purity should exceed 90%)
Western blotting with anti-His antibodies to verify tag presence
Mass spectrometry to confirm protein identity and detect potential modifications
Circular dichroism spectroscopy to assess proper protein folding
2. Functional activity assessment:
Iron binding assays using isothermal titration calorimetry
Reconstitution into proteoliposomes to verify transport activity
Complementation assays in yeast mitoferrin-deficient strains
3. Stability monitoring:
Real-time stability testing under various storage conditions
Thermal shift assays to determine protein stability
Limited proteolysis to assess structural integrity
Dynamic light scattering to detect aggregation
4. Batch consistency checks:
Establish standard reference samples for batch-to-batch comparison
Maintain detailed records of expression conditions and purification procedures
Implement consistent quality thresholds for experimental use
5. Endotoxin testing:
For cell-based applications, verify endotoxin levels are below acceptable thresholds
Use endotoxin removal methods if necessary
Quality control benchmarks for recombinant Mitoferrin-2B:
| Parameter | Specification | Method | Frequency |
|---|---|---|---|
| Purity | >90% | SDS-PAGE | Each batch |
| Identity | Match to expected sequence | Mass spectrometry | Each new preparation |
| Tag presence | Positive signal | Western blot (anti-His) | Each batch |
| Endotoxin level | <0.1 EU/μg protein | LAL assay | Each batch |
| Functional activity | Transport activity >80% of standard | Iron transport assay | Each batch |
| Stability | <10% degradation | SDS-PAGE after incubation | Each storage condition |
Regular implementation of these quality control measures ensures that experimental outcomes reflect true biological phenomena rather than artifacts from protein degradation or inactivity .
Optimizing transfection of Mitoferrin-2B constructs in Xenopus systems requires different approaches for oocytes versus embryos:
For Xenopus oocytes:
Microinjection technique:
Use glass capillary needles with 10-20 μm tip diameter
Inject 50-100 nl of capped mRNA (concentration 0.1-1 μg/μl)
Target the animal hemisphere for nuclear-destined constructs
Allow 24-48 hours for optimal protein expression
Expression vector selection:
Use vectors containing Xenopus β-globin 5' and 3' UTRs for enhanced stability
Include a Kozak consensus sequence for efficient translation
Consider oocyte-specific promoters for DNA constructs
Electrophysiological recording optimization:
For Xenopus embryos:
Microinjection parameters:
Inject at 1-2 cell stage (within 90 minutes post-fertilization)
Use 2-10 nl volume with mRNA concentration of 50-500 pg/nl
Target specific blastomeres for tissue-restricted expression
Co-inject with lineage tracers (e.g., fluorescent dextrans)
Alternative methods:
Expression verification:
Include reporter tags (GFP, mCherry) for visualization
Western blotting of embryo lysates at different timepoints
Whole-mount immunohistochemistry for spatial expression pattern
Xenopus oocytes have historically served as an excellent expression system for transporters and channels, making them particularly suitable for functional studies of Mitoferrin-2B .
When comparing Mitoferrin-2B studies between Xenopus and mammalian systems, researchers should consider several key differences and complementary advantages:
Structural and functional conservation:
Xenopus Mitoferrin-2B and mammalian Mitoferrin-2 share significant sequence homology, suggesting conserved core functions
Both are members of the solute carrier family 25 (SLC25A28)
Both localize to the inner mitochondrial membrane and function in iron transport
Experimental advantages of Xenopus:
Developmental accessibility:
Unique methodological approaches:
Advantages of mammalian systems:
Closer evolutionary relationship to humans:
More directly relevant for biomedical applications
Conserved regulatory networks and interaction partners
Available genetic tools:
Extensive collections of knockout and knockin mouse models
Well-established mammalian cell culture systems with CRISPR screening capabilities
Comparative experimental design:
Use Xenopus for initial functional characterization and high-throughput screening
Validate key findings in mammalian cell lines and mouse models
Capitalize on Xenopus for mechanistic studies requiring embryological manipulations
Leverage mammalian systems for physiological integration and disease modeling
Xenopus research has historically provided fundamental insights that predated confirmatory findings in mammals, suggesting its continued value in understanding novel aspects of Mitoferrin-2B function .
Evolutionary analysis of Mitoferrin-2B across species can reveal critical insights about functional domains and conserved mechanisms of action:
1. Sequence conservation patterns:
Multiple sequence alignment of Mitoferrin-2B from fish to mammals can identify:
Invariant residues likely essential for core transport function
Variable regions that may confer species-specific regulation
Lineage-specific insertions or deletions with potential functional significance
2. Phylogenetic relationships:
Construction of phylogenetic trees can reveal:
Duplication events leading to paralogous transporters
Rates of evolutionary change across different lineages
Correlation between sequence divergence and environmental adaptations
3. Structural conservation mapping:
Homology modeling based on crystallized transporters in the same family can identify:
Conserved transmembrane domains forming the transport channel
Substrate binding sites with high evolutionary constraint
Regulatory domains subject to species-specific selection
4. Functional domain prediction:
Evolutionary trace methods can identify:
Co-evolving residues indicating functional interaction networks
Functional motifs conserved across the mitochondrial carrier family
Potential interaction surfaces with partner proteins
5. Selection pressure analysis:
Calculation of dN/dS ratios can reveal:
Domains under purifying selection (functionally constrained)
Regions under positive selection (potentially adapting to different iron requirements)
Lineage-specific selection patterns
The evolutionary position of Xenopus between aquatic vertebrates and land tetrapods makes it particularly valuable for identifying conserved versus derived features of Mitoferrin-2B function . This comparative approach can guide the design of targeted mutagenesis experiments to test functional hypotheses.
Research on Xenopus Mitoferrin-2B offers valuable insights into human mitochondrial iron disorders through multiple translational pathways:
1. Functional conservation relevance:
Human and Xenopus Mitoferrin proteins share conserved functional domains
Mechanisms of iron transport across the inner mitochondrial membrane are evolutionarily conserved
This conservation allows modeling of human disease-associated mutations in the Xenopus system
2. Disease mechanism modeling:
Xenopus embryos can be manipulated to mimic conditions seen in:
Sideroblastic anemias (characterized by mitochondrial iron overload)
Friedreich's ataxia (involving mitochondrial iron dysregulation)
Various mitochondrial myopathies with iron metabolism components
Using morpholinos or CRISPR-based approaches to create loss-of-function phenotypes that parallel human conditions
3. High-throughput screening applications:
Xenopus embryos can be used to screen:
Compounds that correct iron transport deficiencies
Genetic modifiers of Mitoferrin-2B function
Factors that enhance or rescue mitochondrial iron homeostasis
4. Mechanistic insights from embryological studies:
Developmental consequences of Mitoferrin dysfunction can reveal:
Critical periods where iron transport is essential
Tissue-specific requirements for mitochondrial iron
Compensatory mechanisms that might be therapeutically relevant
5. Xenopus-specific experimental advantages:
Large-scale biochemical studies feasible with Xenopus egg extracts
Tissue-specific knockdown possible through targeted microinjection
The phylogenetic position of Xenopus as a tetrapod vertebrate with conserved cellular and developmental organization with mammals enhances the translational relevance of findings to human disease contexts .
To investigate Mitoferrin-2B's role in iron-dependent developmental processes, researchers can employ these methodological approaches tailored to the Xenopus model system:
1. Spatiotemporal expression mapping:
Whole-mount in situ hybridization to visualize slc25a28-b expression patterns throughout development
Immunohistochemistry with anti-Mitoferrin-2B antibodies to track protein localization
Transgenic reporter lines with the slc25a28-b promoter driving fluorescent protein expression
Quantitative RT-PCR on dissected tissues to measure expression levels at key developmental stages
2. Loss-of-function approaches:
Targeted microinjection of morpholinos against slc25a28-b into specific blastomeres
CRISPR/Cas9-mediated mutagenesis (particularly effective in X. tropicalis)
Dominant negative constructs designed to interfere with endogenous Mitoferrin-2B function
3. Rescue and gain-of-function studies:
mRNA rescue experiments with wild-type or mutant Mitoferrin-2B
Iron supplementation to bypass transport defects
Transgenic overexpression to evaluate effects of increased mitochondrial iron import
4. Iron-dependent process assessment:
Hemoglobin synthesis measurement using o-dianisidine staining
Activity assays for iron-sulfur cluster-containing enzymes
Mitochondrial respiration measurement in isolated mitochondria
Iron staining techniques (Perls' Prussian blue) to visualize iron accumulation
Fluorescent iron sensors for dynamic iron imaging in living embryos
5. Integration with developmental staging:
Targeted analysis at key developmental transitions (gastrulation, neurulation, organogenesis)
Metamorphosis studies examining changes in iron requirements during this iron-demanding process
Lineage tracing combined with iron transport assessment in specific tissue derivatives
These approaches leverage the unique advantages of the Xenopus system, including external development, ease of manipulation, and embryological accessibility, to provide comprehensive insights into the developmental functions of Mitoferrin-2B .